Private equity firm Altus Capital Partners has acquired specialised spinal implants manufacturer ChoiceSpine for an undisclosed sum.

ChoiceSpine also designs and markets instrumentation and biologics for the surgical treatment of complex spine disorders.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

ChoiceSpine and Knox Spine develop new products in collaboration with physicians. Products incorporate existing medical technology with customised patient solutions.

Altus Capital Partners co-founder and senior partner Gregory Greenberg said: “We recognise the need in the medical technology space for proven spinal products that can enhance the quality of life for spinal patients.

“ChoiceSpine, a global medical device corporation specialising in innovative solutions for both spinal fusion hardware and biologics, demonstrates a track record of proven innovation, strong sales growth, increased distribution and the necessity of their products in the marketplace.”

“We recognise the need in the medical technology space for proven spinal products that can enhance the quality of life for spinal patients.”

The company’s management will continue to invest in the expansion of the business.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The latest deal is said to be Altus’s second acquisition in the medical technology space.

In December last year, the company completed the tender offer to acquire all of the outstanding shares of common stock of global medical technology company dedicated to cardiorespiratory health solutions, MGC Diagnostics.

ChoiceSpine founder Marty Altshuler said: “We look forward to working with Altus in further developing our offerings as well as expanding into new product verticals to continue to grow the company and provide patient solutions for the treatment of spinal disorders.”

ChoiceSpine manufactures minimally invasive, cervical, thoracolumbar, interbody, lateral, and biologics kits and implants.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact